Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03031847 · ClinicalTrials.gov registry record · NA
Cardiac Resynchronization in the Elderly
A NA study, sponsored by Samir Saba.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT03031847 is a NA study that has completed, run by Samir Saba. The registered enrollment target is 102 participants.
The verdict
NCT03031847, a NA study, has completed, sponsored by Samir Saba.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
This pilot will enroll 50 HF patients (age ≥ 75 years) undergoing CRT device implantation at the hospitals of the University of Pittsburgh Medical Center, Duke University, Ohio State University, and the VA Pittsburgh Healthcare System. Patients will be randomized to CRT-P versus CRT-D and followed until study end. Rates of patient screening, enrollment, randomization, and retention as well as cost of care will be examined. The results of this pilot study will inform the design of a large pivotal non-inferiority trial and will be necessary for its success. Patients who refuse participation in the randomized pilot trial will be asked to enroll in a prospective observational cohort. Characteristics of patients who choose CRT-P vs. CRT-D will be compared and patients' level of satisfaction with their device decision will be measured.
Interventions
- DEVICE Cardiac Resynchronization Therapy Pacemaker
- DEVICE Cardiac Resynchronization Therapy Defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-03-21 |
| Est. Completion | 2021-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03031847
The ClinicalTrials.gov registry entry for NCT03031847 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Samir Saba, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cardiac Resynchronization Therapy Pacemaker is the first listed.
NCT03031847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03031847 about?
NCT03031847 is a clinical study titled "Cardiac Resynchronization in the Elderly". This pilot will enroll 50 HF patients (age ≥ 75 years) undergoing CRT device implantation at the hospitals of the University of Pittsburgh Medical Center, Duke University, Ohio State University, and the VA Pittsburgh Healthcare System. Patients will be randomized to CRT-P versus CRT-D and followed u...
What is the current status of trial NCT03031847?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2017-03-21. Estimated completion is 2021-08-18.
What interventions are being tested in trial NCT03031847?
The interventions under investigation include: Cardiac Resynchronization Therapy Pacemaker (DEVICE), Cardiac Resynchronization Therapy Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT03031847?
This trial is sponsored by Samir Saba, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.